Envoy Medical, Inc. (COCH): Cost of Revenue

Annual figures by period end, from SEC filings.

$874.0K

Year ended 2025-12-31

$1.00M

Trailing 12 months to 2026-06-30

+20.6%

3-year compound annual growth

2022-12-31 Cost of Revenue (USD) 2025-12-31

Period ended	Cost of Revenue	Change YoY	Source filing
2025-12-31	$874.0K	+17.8%	2026-03-23, From 2025-01-01
2024-12-31	$742.0K	-6.0%	2026-03-23, From 2024-01-01
2023-12-31	$789.0K	+58.4%	2025-03-31, From 2023-01-01
2022-12-31	$498.0K	n/a	2024-04-01, From 2022-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
Envoy Medical, Inc. (COCH)	2025-12-31	$874.0K	+17.8%
Safe Pro Group Inc. (SPAI)	2025-12-31	$404.5K	-68.0%
Anteris Technologies Global Corp. (AVR)	2025-12-31	$569.0K	-60.4%
NutriBand Inc. (NTRB)	2026-01-31	$1.47M	+5.3%
CollPlant Biotechnologies Ltd (CLGN)	2025-12-31	$835.0K	-48.6%
ENvue Medical, Inc. (FEED)	2025-12-31	$2.40M	+128.6%
Milestone Scientific Inc. (MLSS)	2025-12-31	$2.57M	+16.9%
LogicMark, Inc. (LGMK)	2025-12-31	$3.79M	+15.5%
Jin Medical International Ltd. (ZJYL)	2025-09-30	$14.64M	+4.6%

Compare COCH, SPAI, AVR, NTRB side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗